HIV-1 Vpr Modulates Macrophage Metabolic Pathways: A SILAC-Based Quantitative Analysis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Barrero, Carlos A ^a   Datta, Prasun K ^a   Sen, Satarupa ^a,b   Deshmane, Satish ^a   Amini, Shohreh ^a,b   Khalili, Kamel ^a   Merali, Salim ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADENYLATE KINASE 2; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 2; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXIDOREDUCTASE; PENTOSE PHOSPHATE; PHOSPHOTRANSFERASE; PYRUVATE KINASE; PYRUVATE KINASE MUSCLE TYPE 2; PYRUVIC ACID; TRANSKETOLASE; UNCLASSIFIED DRUG; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOGENESIS; BIOINFORMATICS; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EXCITOTOXICITY; GENE OVEREXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LONG TERM SURVIVAL; MACROPHAGE; MASS SPECTROMETRY; MONOCYTE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; STABLE ISOTOPE LABELING BY AMINO ACID IN CELL CULTURE; UPREGULATION; VALIDATION STUDY; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; WESTERN BLOTTING;

BLOTTING, WESTERN; COMPUTATIONAL BIOLOGY; GLYCOLYSIS; HUMANS; ISOTOPE LABELING; MACROPHAGES; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TRANSDUCTION, GENETIC; U937 CELLS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84880081958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068376     Document Type: Article

References (69)

1. Amini S, Khalili K, Sawaya BE, (2004) Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol 23: 249-260.
2. Le Rouzic E, Benichou S, (2005) The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2: 11.
3. Planelles V, Benichou S, (2009) Vpr and its interactions with cellular proteins. Curr Top Microbiol Immunol 339: 177-200.
4. Kogan M, Rappaport J, (2011) HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8: 25.
5. Zhao RY, Li G, Bukrinsky MI, (2011) Vpr-host interactions during HIV-1 viral life cycle. J Neuroimmune Pharmacol 62: 216-229.
6. Sharifi HJ, Furuya AM, de Noronha CM, (2012) The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest. Curr Opin HIV AIDS 7: 187-194.
7. Connor RI, Chen BK, Choe S, Landau NR, (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206: 935-944.
8. Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, et al. (2001) HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med 194: 1407-1419.
9. Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, et al. (1998) Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 187: 1103-1111.
10. Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, et al. (2007) Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 4: 84.
11. Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, et al. (2004) High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate withHIV-1-associated dementia. DNA Cell Biol 23: 261-269.
12. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ, (1995) Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 270: 25564-25569.
13. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S, (1998) Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 273: 20052-20057.
14. Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, et al. (2002) HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 277: 37820-37831.
15. Arokium H, Kamata M, Chen I, (2009) Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol 83: 11283-11297.
16. Saxena M, Busca A, Pandey S, Kryworuchko M, Kumar A, (2011) CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner. J Immunol 187: 5865-5878.
17. Patel CA, Mukhtar M, Pomerantz RJ, (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 74: 9717-9726.
18. Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, et al. (2011) Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 286: 34976-34985.
19. Godet AN, Guergnon J, Croset A, Cayla X, Falanga PB, et al. (2010) PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins. PLoS One 5: e13760.
20. Busca A, Saxena M, Kumar A, (2012) Critical role for antiapoptotic Bcl-xL and Mcl-1in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem 287: 15118-15133.
21. Smolka MB, Zhou H, Purkayastha S, Aebersold R, (2001) Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal Biochem 297: 25-31.
22. Zieske LR, (2006) A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57: 1501-1508.
23. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
24. Duan X, Kelsen SG, Clarkson AB Jr R, Merali S, (2010) SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle. Proteomics 10: 2165-2174.
25. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An unusual macrophage-trophic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517-7521.
26. Dyrlund TF, Poulsen ET, Scavenius C, Sanggaard KW, Enghild JJ, (2012) MS Data Miner: A web-based software tool to analyze, compare and share mass spectrometry protein identifications. Proteomics 12: 2792-2796.
27. Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, et al. (2009) Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem 284: 11364-11373.
28. Navare AT, Sova P, Purdy DE, Weiss JM, Wolf-Yadlin A, et al. (2012) Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 429: 37-46.
29. Meléndez LM, Colon K, Rivera L, Rodriguez-Franco E, Toro-Nieves D, (2011) Proteomic analysis of HIV-infected macrophages. J Neuroimmune Pharmacol 6: 89-106.
30. Wiederin J, Rozek W, Duan F, Ciborowski P, (2009) Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 7: 8.
31. Pendyala G, Trauger SA, Kalisiak E, Ellis RJ, Siuzdak G, et al. (2009) Cerebrospinalfluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J Proteome Res 8: 2253-2260.
32. Toro-Nieves DM, Rodriguez Y, Plaud M, Ciborowski P, Duan F, et al. (2009) Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J Neurovirol 15: 36-50.
33. Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, et al. (2008) Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3: e2507.
34. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D, (2008) Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 82: 4320-4330.
35. Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, et al. (2007) HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 185: 37-46.
36. Chen X, Zheng Y, Li H, Mamadou D, Zhang C, et al. (2011) The Vpr gene polymorphism of human immunodeficiency virus type 1 in China and its clinical significance. Curr HIV Res 9: 295-299.
37. Wu JQ, Dyer WB, Chrisp J, Belov L, Wang B, et al. (2008) Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology 5: 24.
38. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2008) Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology 380: 124-135.
39. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2011) Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology 8: 18.
40. Wu JQ, Sassé TR, Wolkenstein G, Conceicao V, Saksena MM, et al. (2013) Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology 435: 308-319.
41. Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, et al. (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13: 677.
42. Marín-Hernández A, Gallardo-Pérez JC, Rodríguez-Enríquez S, Encalada R, Moreno-Sánchez R, et al. (2011) Modeling cancer glycolysis. Biochim Biophys Acta 1807: 755-767.
43. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V, (2004) In self-defense: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377: 347-355.
44. Stanton RC, (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64: 362-369.
45. Cosentino C, Grieco D, Costanzo V, (2011) ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30: 546-555.
46. Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732-744.
47. Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, et al. (2006) Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 1123: 226-236.
48. Rivera-Rivera L, Perez-Laspiur J, Colón K, Meléndez LM, (2012) Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J Neurovirol 18: 20-29.
49. Gao X, Wang H, Yang JJ, Liu X, Liu ZR, (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598-609.
50. Yang W, Xia Y, Hawke D, Li X, Liang J, et al. (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150: 685-696.
51. Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, et al. (2011) Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. J Biol Chem 286: 22211-22218.
52. Tjernlund A, Walther-Jallow L, Behbahani H, Screpanti V, Nowak P, et al. (2007) Leukemia inhibitor factor (LIF) inhibits HIV-1 replication via restriction of stat 3 activation. AIDS Res Hum Retroviruses 23: 398-406.
53. Raimundo N, Baysal BE, Shadel GS, (2011) Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 17: 641-649.
54. Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, et al. (2010) Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol 8: e1000328.
55. Hollenbaugh JA, Munger J, Kim B, (2011) Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology 415: 153-159.
56. Sargent PJ, Farnaud S, Evans RW, (2005) Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem 12: 2683-2693.
57. Tacchini L, Gammella E, De Ponti C, Recalcati S, Cairo G, (2008) Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J Biol Chem 283: 20674-20686.
58. Takeuchi S, (2006) Molecular cloning, sequence, function and structural basis of human heart 150 kDa oxygen-regulated protein, an ER chaperone. Protein J 25: 517-528.
59. Ni M, Lee AS, (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651.
60. Cechowska-Pasko M, Bankowski E, Chene P, (2006) The effect of hypoxia on the expression of 150 kDa oxygen-regulated protein (ORP 150) in HeLa cells. Cell Physiol Biochem 17: 89-96.
61. Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, et al. (2011) Global landscape of HIV-human protein complexes. Nature 481: 365-370.
62. Merk M, Baugh J, Zierow S, Leng L, Pal U, et al. (2009) The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J Immunol 182: 6896-6906.
63. Yedavalli VS, Jeang KT, (2011) Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology 20 8: 61.
64. Hayes JD, Pulford DJ, (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
65. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z, (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases Cancer Research. 60: 4053-4057.
66. Plaitakis A, Latsoudis H, Spanaki C, (2011) The human GLUD2 glutamate dehydrogenase and its regulation in health and disease. Neurochem Int 59: 495-509.
67. Noma T, (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Invest 52: 127-136.
68. Lee HJ, Pyo JO, Oh Y, Kim HJ, Hong SH, et al. (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 29: 1303-1310.
69. Zhao J, Zhong CJ, (2009) A review on research progress of transketolase. Neurosci Bull 25: 94-99.